Andersons pediatric cardiology 2367
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (95.54 KB, 3 trang )
Nightingale,Florence,1481
Nikaidohprocedure,690–692,691f
NIRS,Near-infraredspectroscopy
Nitricoxide
circulatingpoolof,1368–1369
incontrolofcirculation,1359
inendothelialfunction,1356
Nitricoxidesynthase3polymorphism,arterialdysfunctionand,1371
Nkx2-5
cardiacdevelopmentand,50–51
mutationsof,53–54,54f
NNECDSG,NorthernNewEnglandCardiovascularDiseaseStudyGroup
Nonabsorbablesutures,220
Non-adherencewiththerapy,followingcardiactransplantation,1238
Noncardiacsurgery,anesthesiainpatientswithcongenitalheartdiseasefor,
1551–1552,1551t
Nonfinancialcosts,incongenitalheartdisease,188,188b
Noninvasivebloodpressuremonitoring,inFontanpathway,1274,1274t,1288
Nonlinearregression,414
Nonsteroidalantiinflammatorydrugs,forhemodynamicallysignificantarterial
duct,198–199
Non-syndromicmutations,53–56
Noonansyndrome,53
hypertrophiccardiomyopathyand,1147
Noradrenaline
foracutecirculatoryfailure,1185
forcontrolofcirculation,1357
Norepinephrine,foracutecirculatoryfailure,1184t
NorthernNewEnglandCardiovascularDiseaseStudyGroup(NNECDSG),
1515–1516
Norwoodprocedure,1378
withsystemic-to-pulmonaryartery(Blalock-Taussig)shunt,1281–1282,1282f–1283f
NOTCH1,mutationsof,55–56,56f
Novelnoninvasivealgorithms,inFontanpathway,1275,1288–1289
Nuclearperfusionimaging,exercisetestingand,396–397,397f
Nucleus,ofcardiomyocyte,67
Numerator,definitionof,174
Nutrition
cardiovascularriskfactorsand,425
growthand,1495–1503
forinterstagemanagement,1307–1308,1312–1313
managementof,inFontanpathway,1278,1291–1292
systemicarterialdysfunctionand,1372
Nutritionaldeficiencies,inFontanpathway,1295
Nutritionalmanagement,1498–1499
feedingroutesand,1500
withFontancirculation,1503
infantnutritionalrequirementsand,1498
forinfantswithlowweight,1500
forinpatients,1502
maximizingcaloriesand,1502
outpatientnutritionchallengesfor,1502
foroutpatients,1502
parenteralnutritionand,1499–1500
forpatientsrequiringmechanicalsupport,1502
postoperativenutritionand,1499
prostaglandinand,1498–1499
withumbilicalarterialcatheters,1499
O
Obesity
cardiovascularriskfactorsand,425–426
congenitalheartdiseaseand,1502–1503
hypertensionand,1124
systemicarterialdysfunctionand,1371
Obliquesinus,17,19f
Observationalstudies,415–418,416t
causalityfrom,417–418,418b
ObstructedTAPVC,487
Obstruction,incardiactumors,965–966,966f
Okihirosyndrome,53
Ontogeny,1429
Opensternum,219–220
Openvalvotomy,832
Oralanticoagulation,forpulmonaryhypertension,1389
Oralcontraceptionwithcongenitalheartdisease,1442,1442t
Oralfeeding,1500
Oralprostacyclinanalogues,forpulmonaryhypertension,1389–1390
Organprocurement,incardiactransplantation,1476–1477
Organelle,turnover,69
Organicaniontransportingpolypeptides,1435
Organiccationtransporters,1435
Orificialatresia,coronary,875–876
clinicalpresentationof,875
diagnostictestingof,875–876
outcomesfor,876
pathophysiologyof,875
surgicaltechniquefor,876
Oscillometricdevicesforbloodpressuremeasurement,1116
